2022 annual financial data
Skye Bioscience, Inc. 2022 Operating margin
Skye Bioscience, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -18,311,732 USD and net income was -19,481,602 USD.
Operating cash flow was -12,744,072 USD.
Get free Skye Bioscience, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,311,732 USD
- Net income
- -19,481,602 USD
- Operating cash flow
- -12,744,072 USD